stockrowOmnicell, Inc. (OMCL) vs Phreesia, Inc. (PHR)
- Omnicell, Inc. OMCL 37.33 −1.84%
- Phreesia, Inc. PHR 12.56 −1.18%
Omnicell, Inc. and Phreesia, Inc. are both Health Information Services companies. Omnicell, Inc. is the larger, with a market value of $1.7B against $788.9M — 2.2× the size. Omnicell, Inc. trades at the lower P/E: 39.0× against 74.4×. Phreesia, Inc. grew revenue faster over the last twelve months: 12.9% against 5.62%. Omnicell, Inc. has the higher net margin (3.59% vs 2.06%) and the higher return on invested capital (3.45% vs 1.74%). Across the 22 metrics below, Omnicell, Inc. leads on 12 and Phreesia, Inc. on 10.
Valuation
Profitability
| Metric | OMCL | PHR | Health Information Services median |
|---|---|---|---|
| Gross margin | 45.14% | 67.52% | 59.61% |
| Operating margin | 5.20% | 2.47% | (10.54%) |
| Net margin | 3.59% | 2.06% | (16.14%) |
| Free cash flow margin | 10.67% | 13.30% | 0.00% |
| Return on equity | 0.00% | 3.12% | (3.15%) |
| Return on assets | 2.23% | 1.98% | (5.62%) |
| Return on invested capital | 3.45% | 1.74% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack